NO993846D0 - Metode for deteksjon og lokalisering av maligne, humane tumorer - Google Patents
Metode for deteksjon og lokalisering av maligne, humane tumorerInfo
- Publication number
- NO993846D0 NO993846D0 NO993846A NO993846A NO993846D0 NO 993846 D0 NO993846 D0 NO 993846D0 NO 993846 A NO993846 A NO 993846A NO 993846 A NO993846 A NO 993846A NO 993846 D0 NO993846 D0 NO 993846D0
- Authority
- NO
- Norway
- Prior art keywords
- detection
- composition
- relates
- neurotensin
- malignant tumors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/085—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being neurotensin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Radiation-Therapy Devices (AREA)
- Nuclear Medicine (AREA)
- External Artificial Organs (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97200297 | 1997-02-03 | ||
| PCT/US1998/001964 WO1998033531A1 (en) | 1997-02-03 | 1998-02-02 | Method for the detection and localization of malignant human tumours |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993846D0 true NO993846D0 (no) | 1999-08-10 |
| NO993846L NO993846L (no) | 1999-09-09 |
Family
ID=26146106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993846A NO993846L (no) | 1997-02-03 | 1999-08-10 | Metode for deteksjon og lokalisering av maligne, humane tumorer |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6312661B1 (no) |
| EP (1) | EP0968001B1 (no) |
| JP (1) | JP2001511152A (no) |
| AT (1) | ATE253381T1 (no) |
| AU (1) | AU728712C (no) |
| CA (1) | CA2279530C (no) |
| DE (1) | DE69819478T2 (no) |
| HU (1) | HUP0001316A3 (no) |
| IL (1) | IL131386A0 (no) |
| NO (1) | NO993846L (no) |
| WO (1) | WO1998033531A1 (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3340699B2 (ja) * | 1998-06-05 | 2002-11-05 | 東京瓦斯株式会社 | 膵外分泌機能診断剤 |
| US7232559B1 (en) | 1999-06-04 | 2007-06-19 | Tokyo Gas Company Limited | Diagnostic agents for pancreatic exocrine function |
| AU2119101A (en) * | 1999-10-22 | 2001-05-08 | Insight Neuroimaging Systems, Llc | Ligand chelated paramagnetic mri contrast agents |
| US8175890B2 (en) * | 2001-10-30 | 2012-05-08 | Biodose, Llc | Pharmacy based method and algorithm for handling of radioactive pharmaceuticals and generating of reports therefrom |
| US7630907B2 (en) * | 2001-10-30 | 2009-12-08 | Biodose, Llc | Algorithm and program for the handling and administration of radioactive pharmaceuticals |
| US7794693B2 (en) | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
| CA2513044A1 (en) | 2002-03-01 | 2004-08-05 | Dyax Corp. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| US7211240B2 (en) | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
| US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
| US20040039241A1 (en) * | 2002-05-29 | 2004-02-26 | Biodose Llc | Integrated distribution and communication process and algorithm for providing, handling, distributing or generating reports regarding radioactive pharmaceuticals |
| WO2004009614A2 (en) * | 2002-07-24 | 2004-01-29 | The Salk Institute For Biological Studies | Receptor (sstr4)- selective somatostatin analogs |
| GR1004637B (el) * | 2003-04-04 | 2004-07-23 | Βιομεντικααλαιφασαιενσισαανωνυμηαεταιριααφαρμακευτικωναπροιοντωναα | Συνθεσηαβιολογικηακαιαπροκλινικηααξιολογησηααναλογωνανευροτενσινησα}@@bατροποποιημενωναμεαπαραγωγαατουα@ϊ@τετρααζαενδεκανιουα}@ϊ@tetraazaundecanebακαιαεπισημασμενωναμεατεχνητιο@mα}αηαλλααραδιονουκλιδιαατουατεχνητιουbαη@καιαρηνιο@ϊϊα}΄ηααλλααραδιονουκλιδιαατουαρηνιουbαγιααεφαρμογηαστηναογκολογιαα |
| CN1867363B (zh) * | 2003-09-17 | 2010-05-12 | 得克萨斯大学体系董事会 | 用于使胰腺显像的组合物及其用途 |
| US7507547B2 (en) * | 2004-09-09 | 2009-03-24 | University Of Massachusetts | Screening assays for antioxidants and antiproliferative compounds |
| US20060062729A1 (en) * | 2004-09-09 | 2006-03-23 | Carraway Robert E | Enhanced ligand binding to neurotensin receptors |
| EP2374003B1 (en) | 2009-01-07 | 2015-03-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment, the prognostic assessment and the detection of breast cancer |
| US9809624B2 (en) * | 2009-07-16 | 2017-11-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors |
| US8378134B2 (en) | 2009-09-30 | 2013-02-19 | General Electric Company | Hydroxylated contrast enhancement agents |
| EP2740726A1 (en) | 2012-12-07 | 2014-06-11 | 3B Pharmaceuticals GmbH | Neurotensin receptor ligands |
| CN106794264B (zh) | 2014-06-10 | 2021-03-23 | 3B制药有限公司 | 包含神经降压肽受体配体的缀合物及其用途 |
| EP2954933A1 (en) | 2014-06-10 | 2015-12-16 | 3B Pharmaceuticals GmbH | Conjugate comprising a neurotensin receptor ligand |
| EP2954934A1 (en) | 2014-06-11 | 2015-12-16 | 3B Pharmaceuticals GmbH | Conjugate comprising a neurotensin receptor ligand and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2687680A1 (fr) * | 1992-02-20 | 1993-08-27 | Centre Nat Rech Scient | Procede de marquage de proteines et de peptides par acylation de leur fonction alpha aminee par un reactif comportant une fonction carboxylique activee. |
| WO1993018797A1 (en) * | 1992-03-25 | 1993-09-30 | Mallinckrodt Medical, Inc. | Method of intraoperatively detecting and locating tumoral tissues |
| CA2086453A1 (en) * | 1992-12-30 | 1994-07-01 | Mcgill University | Marker for neurotensin receptor |
| DE4337599A1 (de) * | 1993-11-01 | 1995-05-04 | Diagnostikforschung Inst | Metallbindende cysteinfreie Peptide für Diagnose und Therapie, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| EP0752873A4 (en) * | 1994-02-18 | 2002-05-15 | Mallinckrodt Inc | MARKED PEPTIDE COMPOUNDS |
| FR2720066B1 (fr) * | 1994-05-20 | 1996-06-28 | Rhone Poulenc Rorer Sa | Peptides antagonistes de la neurotensine. |
| FR2722193B1 (fr) * | 1994-07-08 | 1996-10-04 | Sanofi Sa | Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant |
| WO1996023527A1 (en) * | 1995-02-03 | 1996-08-08 | Mallinckrodt Medical, Inc. | Method for the detection and localization of malignant human tumours |
-
1998
- 1998-02-02 EP EP98904839A patent/EP0968001B1/en not_active Expired - Lifetime
- 1998-02-02 CA CA002279530A patent/CA2279530C/en not_active Expired - Lifetime
- 1998-02-02 AU AU62622/98A patent/AU728712C/en not_active Ceased
- 1998-02-02 HU HU0001316A patent/HUP0001316A3/hu unknown
- 1998-02-02 WO PCT/US1998/001964 patent/WO1998033531A1/en not_active Application Discontinuation
- 1998-02-02 DE DE69819478T patent/DE69819478T2/de not_active Expired - Lifetime
- 1998-02-02 US US09/355,869 patent/US6312661B1/en not_active Expired - Lifetime
- 1998-02-02 IL IL13138698A patent/IL131386A0/xx unknown
- 1998-02-02 JP JP53317698A patent/JP2001511152A/ja active Pending
- 1998-02-02 AT AT98904839T patent/ATE253381T1/de not_active IP Right Cessation
-
1999
- 1999-08-10 NO NO993846A patent/NO993846L/no not_active Application Discontinuation
-
2001
- 2001-11-05 US US09/985,672 patent/US20020155064A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE253381T1 (de) | 2003-11-15 |
| DE69819478D1 (de) | 2003-12-11 |
| US6312661B1 (en) | 2001-11-06 |
| EP0968001B1 (en) | 2003-11-05 |
| NO993846L (no) | 1999-09-09 |
| CA2279530A1 (en) | 1998-08-06 |
| CA2279530C (en) | 2009-04-28 |
| HUP0001316A2 (hu) | 2000-09-28 |
| IL131386A0 (en) | 2001-01-28 |
| AU728712B2 (en) | 2001-01-18 |
| DE69819478T2 (de) | 2004-09-02 |
| AU6262298A (en) | 1998-08-25 |
| US20020155064A1 (en) | 2002-10-24 |
| HUP0001316A3 (en) | 2001-10-29 |
| EP0968001A1 (en) | 2000-01-05 |
| WO1998033531A1 (en) | 1998-08-06 |
| JP2001511152A (ja) | 2001-08-07 |
| AU728712C (en) | 2001-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993846D0 (no) | Metode for deteksjon og lokalisering av maligne, humane tumorer | |
| Mitran et al. | Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist 177Lu‐DOTAGA‐PEG2‐RM26 | |
| US11547767B2 (en) | 99mTc-EDDA/HYNIC-iPSMA as a radiopharmaceutical for detecting the overexpression of prostate-specific membrane antigen | |
| CN101631801B (zh) | 受体（sstr2）-选择性生长抑素拮抗剂 | |
| Tjuvajev et al. | Iododeoxyuridine uptake and retention as a measure of tumor growth | |
| Ruserb et al. | Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer | |
| Bonnet‐Duquennoy et al. | Targeted radionuclide therapy of melanoma: anti‐tumoural efficacy studies of a new 131I labelled potential agent | |
| US20060188441A1 (en) | Radiolabeled gallium complexes, methods for synthesis and use for PET imaging of EGFR expression in malignant tumors | |
| Liu et al. | 99mTc-labeled SWL specific peptide for targeting EphA2 receptor | |
| N Eberle et al. | Synthetic peptide drugs for targeting skin cancer: malignant melanoma and melanotic lesions | |
| Nagy et al. | Targeted cytotoxic somatostatin analogs: a modern approach to the therapy of various cancers | |
| O'Byrne et al. | Scintigraphic imaging of small-cell lung cancer with [111In] pentetreotide, a radiolabelled somatostatin analogue | |
| Guo et al. | A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging | |
| JPH04506343A (ja) | ターゲッティング薬剤 | |
| ES2294818T3 (es) | Procedimiento para reconocimiento y determinacion receptores gnrh y utilizacion de agonistas de gnrh y antagonistas de gnrh y otros ligandos receptor de gnrh para tratamiento tumores con receptores de gnrh,que provienen cerebro y/o sistema nervioso y/o meninges y/o sarcoma kaposi. | |
| Nock et al. | Theranostic perspectives in prostate cancer with the GRPR-antagonist NeoBOMB1–preclinical and first clinical results | |
| Liu et al. | In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone | |
| AU2020356262B2 (en) | Radiolabelled GRPR-antagonist for use as theragnostic | |
| Arista et al. | Intralesional administration of I-131 labelled monoclonal antibodies in the treatment of malignant gliomas | |
| JP2002516882A5 (no) | ||
| JP2022517662A (ja) | 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドｐｅｔ／ｓｐｅｃｔプローブ | |
| WO2016061583A1 (en) | Compositions and methods for treating pituitary tumors | |
| CN113316721A (zh) | 用于靶向甲状腺髓样癌的组合物 | |
| Varshney et al. | Targeting Bombesin Peptide Receptors for Cancer Imaging: Perspective in Prostate, Lung and Breast Cancer | |
| WO1997031657A3 (en) | Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |